Disc Medicine, Inc.
IRON
$38.73
$3.509.94%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 51.18% | 54.41% | 50.88% | 46.49% | 55.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.35% | 63.39% | 63.33% | 55.59% | 91.94% |
| Operating Income | -42.35% | -63.39% | -63.33% | -55.59% | -91.94% |
| Income Before Tax | -42.80% | -61.29% | -37.55% | -34.80% | -63.00% |
| Income Tax Expenses | 258.59% | 214.93% | 148.94% | 252.17% | -- |
| Earnings from Continuing Operations | -43.08% | -61.45% | -37.63% | -34.88% | -63.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.08% | -61.45% | -37.63% | -34.88% | -63.22% |
| EBIT | -42.35% | -63.39% | -63.33% | -55.59% | -91.94% |
| EBITDA | -42.34% | -63.38% | -63.29% | -55.67% | -92.09% |
| EPS Basic | -14.18% | 63.90% | 86.56% | 90.79% | 92.43% |
| Normalized Basic EPS | -14.26% | 63.16% | 86.31% | 90.82% | 92.46% |
| EPS Diluted | -14.18% | 63.90% | 86.56% | 90.79% | 92.43% |
| Normalized Diluted EPS | -14.26% | 63.16% | 86.31% | 90.82% | 92.46% |
| Average Basic Shares Outstanding | 23.75% | 58.65% | 132.22% | 328.41% | 2,045.58% |
| Average Diluted Shares Outstanding | 23.75% | 58.65% | 132.22% | 328.41% | 2,045.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
